Cryoport completes sale of courier business to DHL for $200m
Temperature-controlled solutions company Cryoport has completed the sale of its courier business, focused on focused on clinical trials, biopharma, and cell and gene therapies, to logistics provider DHL Group.
First announced in March, the transaction was valued at around $200m.
Jerrell Shelton, CEO of Cryoport, said the divestment aligns with the company’s long-term strategic vision and allows the company to intensify its focus on advancing its life science service platform.
In addition to the sale, Cryoport and DHL have also formed a strategic partnership to work together on supply chain and logistics opportunities in the life sciences and healthcare sectors.
... to continue reading you must be subscribed
Subscribe Today
To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.
